Company news
Cardiac Biotech Solutions Inc. (OTC:CBSC) news
Cardiac Biotech Solutions Inc. news releases on 6ix. Latest, Jan 15, 2026: Cardiac Biotech Solutions Activates China Production Pipeline for MyCardia…
Press releases & updates
Cardiac Biotech Solutions Activates China Production Pipeline for MyCardia AT and Moves into Final NMPA Submission Phase
January 15, 2026
Cardiac Biotech Solutions, Inc. Secures Health Canada License for MyCardia AT Device, Now Branded as CardioHolter AT
September 25, 2025
CBSC Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical
September 11, 2025
Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina
September 4, 2025
CB Scientific, Inc. (CBSC) Announces Corporate Name Change to Cardiac Biotech Solutions, Inc.
May 8, 2025
CB Scientific Inc. (CBSC) Formally Launches Next Generation MyCardia AT Cardiac Monitor
February 24, 2025
CB Scientific, Inc. Appoints Trip Thomas as Chief Financial Officer
October 2, 2024
CB Scientific, Inc. Announces Voluntary Delisting from OTCQB Venture Market
August 19, 2024
CB Scientific, Inc. Concludes its Annual Meeting of Stockholders
March 18, 2024
CB Scientific, Inc. Announces Exclusive Canadian Distribution Agreement
March 8, 2023
CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor
September 5, 2022
CB Scientific, Inc. (CBSC) and Shenzhen Pump Medical Co., Ltd. Announce Cooperative Manufacturing Agreement for Chinese Market
August 22, 2022
CB Scientific, Inc. Enters Regulatory Testing Phase for Updated myCam Cardiac Event Monitoring Device
May 23, 2022
CB Scientific, Inc. Welcomes James Ott as Chief Technology Officer
May 2, 2022
OTC Markets Group Welcomes New OTCQB Companies – April 11
April 11, 2022
CB Scientific, Inc. Announces Uplist to the OTCQB(R) Venture Market
April 5, 2022
CB Scientific, Inc. Concludes its Annual Audit with MaloneBailey, LLP
March 14, 2022
CB Scientific, Inc. Concludes Its Special Meeting of Stockholders
January 17, 2022
CB Scientific, Inc. to Convene a Special Meeting of Stockholders on Friday, January 14, 2022
January 3, 2022
CB Scientific, Inc. Enters Beta-testing Phase for Its Updated Proprietary My-Cam Cardiac Event Monitor
December 13, 2021
CB Scientific, Inc. Executes Manufacturing Letter of Intent with Shenzhen Pump Medical System Co., Ltd.
December 6, 2021
CB Scientific, Inc. Announces Intent to Convene a Special Meeting of the Stockholders
November 29, 2021
CB Scientific Files Application to Uplist to the OTCQB Venture Market
November 15, 2021
CB Scientific Announces Addition of Brooke Martellaro as Chief Financial Officer
November 1, 2021
CB Scientific, Inc. Appoints Paul Danner as Chairman
October 27, 2021
CB Scientific, Inc. (CBSC) Announces the Engagement of MaloneBailey, LLP
October 4, 2021
CB Scientific, Inc. (CBSC) Announces the Launch of Direct-to-Consumer Heart Wellness Check-Up Program in Bangkok, Thailand
September 27, 2021
CB Scientific, Inc. (CBSC) enters into a Consultant Services Agreement with the Dorchester Group LLC
September 22, 2021
CB Scientific, Inc. (CBSC) Distributor Mango Wellness Comes to an Agreement to Provide Services to Three Major Hospital Chains in Thailand
March 15, 2021
CB Scientific, Inc. Announces Definitive Agreement to Acquire Cardiolink Corporation, an Independent Diagnostic Testing Facility (IDTF)
February 22, 2021
CB Scientific Inc. Stock Symbol CBSC issues a Shareholder Update
February 17, 2021
CB Scientific, Inc. (CBSC) and Shenzhen Semacare Medical Technology Co., Ltd. Announce Collaborative Partnership Agreement
February 10, 2021
CB Scientific, Inc. (CBSC), Distributor Mango Wellness and My Cardia Thailand Well Positioned for Growth in 2021
December 28, 2020
CB Scientific, Inc. (CBSC) Announces Definitive Agreement to Acquire Commercial Ambulatory ECG Device Manufacturer Datrix, LLC
November 12, 2020
CB Scientific, Inc. (CBSC) Announces the Launch of My-Cardia ECG Products and Services in Thailand
October 8, 2020
CB Scientific, Inc. (CBSC) Announces Completion of Asset Purchase Agreement and Commencement of Its ECG Monitoring Business
September 22, 2020
Apotheca Biosciences (PCFP) & CB Scientific Joint Venture to Market Hemp CBD Infused Energy & Chill Drinks Under Brands DAVA & Magic Dragon High
October 8, 2018
Dr. Paul Carney Joins Biotica Pharmaceuticals as Neurologist Consultant and Scientific Advisor
January 2, 2018
CB Scientific’s (CBSC) R & D Focuses on Opioid Crisis, a National Public Health Emergency
October 30, 2017
CB Scientific (CBSC) Secures the Intellectual Patent Rights for Pain-PatchTM, a Cannabinoid Pain Alleviation Technology
September 12, 2017
CB Scientific (CBSC) Completing the Prototyping of Pain-Patch -- a Major Breakthrough in Cannabinoid Pain Alleviation Technology
June 21, 2017
CB Scientific's (CBSC) CannaRAPID an Effective Intervention for Opioid Drug Addiction Patients -- Every Year Close to 28,000 People Die From an Opioid-Related Overdose in America
May 23, 2017
CB Scientific (CBSC) is Launching CannaRAPID, a Novel Sublingual Product for Precise Cannabinoid Dosing -- Optimized with Nanotechnology and Tissue Permeation Enhancing Molecules for Faster Absorption
May 15, 2017
CB Scientific (CBSC) Develops Cannabinoid Delivery Technologies: CannaRAPID(TM), CannaNASAL(TM) & CannaDERME(TM) for Precise & Controlled Release of Cannabinoid Compounds to Various Patient Groups
April 17, 2017
CB Scientific (CBSC) Purchases Marutronics LLC, Inventor of Medical Cannabis Delivery Device -- CB Scientific to Manufacture Proprietary Thermo-Responsive Cannabinoid Delivery Device for Global Delivery
March 13, 2017
CB Scientific (CBSC) Pleased to Announce the Company is Current with OTC Markets
March 2, 2017
CB Scientific (CBSC) Provides Fast Marijuana Test for Police & Military
April 6, 2016